Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease | Zendy

Shulan Zhang | Zendy; Jing Luo | Zendy; Ziyan Wu | Zendy; Dirk Roggenbuck | Zendy; Peter Schierack | Zendy; Dirk Reinhold | Zendy; Ji Li | Zendy; Xiaofeng Zeng | Zendy; Fengchun Zhang | Zendy; Qian Jiaming | Zendy; Yongzhe Li | Zendy

Open Access

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease

Author(s) -

Shulan Zhang,

Jing Luo,

Ziyan Wu,

Dirk Roggenbuck,

Peter Schierack,

Dirk Reinhold,

Ji Li,

Xiaofeng Zeng,

Fengchun Zhang,

Qian Jiaming,

Yongzhe Li

Publication year - 2018

Publication title -

clinical and translational gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.673

H-Index - 35

ISSN - 2155-384X

DOI - 10.1038/ctg.2018.1

Subject(s) - medicine , antibody , ulcerative colitis , intestinal tuberculosis , crohn's disease , immunoglobulin a , inflammatory bowel disease , anti neutrophil cytoplasmic antibody , immunology , disease , gastroenterology , behcet's disease , immunoglobulin g , vasculitis

In comparison with ASCA, aGP2 distinguishes CD from intestinal BD or ITB as disease controls more efficiently, aiding in the differential diagnosis of IBD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research